En Es
Categorías

Eurofins Technologies

Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test kits and lab consumables in the fields of bioanalytical testing for the food, feed, environmental, biopharma, and clinical industries. The company offers a broad range of product test kits for Pathogens ...
Miembro Oro
Productos Covid-19NoticiasResumen
Close

Covid-19 Eurofins Technologies

Laboratorio clínico

SARS-CoV-2 RT-PCR Assays
GSD NovaType Select SARS-CoV-2 Assay Family

GSD NovaType Select is a group of RT-PCR assays to discriminate variants of the SARS-CoV-2 virus. The assay family provides the opportunity to assemble a customized RT-PCR assay mutation panel from a basis kit including the enzyme mastermix, and a range of mutation specific sets, including primer, probes and controls. The research use only (RUO) Select assays detect the following mutations: K417N, K417T, L452R, T478K, E484K, P681R and P618H.
Mas detalles

PRUEBA RT-PCR PARA SARS-COV-2
GSD NovaType III SARS-CoV-2

La GSD NovaType III SARS-CoV-2 RT-PCR está desarrollada para la detección rápida de variantes de preocupación del SARS-CoV-2, incluidas B.1.427 / B.1.429 (Epsilon) / B.1.617.2 (Delta), B.1.617 .1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
Mas detalles

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

SARS-CoV-2 RT-PCR Assay
GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
Mas detalles

SARS-CoV-2 Ag Rapid Test (Nasal Swab)
GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab)

The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen. The CE-IVD labeled rapid test detects SARS-CoV-2 antigens in 15 minutes with a diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%.
Mas detalles

SARS-CoV-2 IgG ELISA Kit
NovaLisa SARS-CoV-2 IgG

The NovaLisa SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The CE-IVD marked assay demonstrates high sensitivity with antibodies detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group), and a specificity of >98%.
Mas detalles

PRUEBA DE SARS-COV-2
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR

La prueba RT-PCR GSD NovaPrime® SARS-CoV-2 (COVID-19) fue diseñada para la determinación cualitativa del ARN genómico del SARS-CoV-2 (síndrome respiratorio agudo severo por el coronavirus 2) extraído de varios tipos de muestras respiratorias humanas.
Mas detalles

PRUEBA DE ANTICUERPOS CONTRA COVID-19
INgezim COVID 19 DR

El ensayo inmunoabsorbente ligado a enzimas de reconocimiento dual (ELISA), puede detectar semicuantitativamente anticuerpos específicos contra la proteína N del virus SARSCoV-2 en una sola muestra de suero o plasma humano.
Mas detalles

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 CROM

The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
Mas detalles
Close

Noticias of Eurofins Technologies

Eurofins to Acquire Genetic Testing Services Provider DNA Diagnostics Center

29 Jun 2021
Eurofins to Acquire Genetic Testing Services Provider DNA Diagnostics Center
Eurofins Scientific (Ebersberg, Germany) has announces that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (DDC; Fairfield, OH, USA).
Más info
Close

Sobre Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test kits and lab consumables in the fields of bioanalytical testing for the food, feed, environmental, biopharma, and clinical industries. The company offers a broad range of product test kits for Pathogens, Allergens, GMOs, Mycotoxins, Veterinary Drugs Residues, Animal Species and Water testing.

Actualizado

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

PRUEBA RT-PCR PARA SARS-COV-2
GSD NovaType III SARS-CoV-2

La GSD NovaType III SARS-CoV-2 RT-PCR está desarrollada para la detección rápida de variantes de preocupación del SARS-CoV-2, incluidas B.1.427 / B.1.429 (Epsilon) / B.1.617.2 (Delta), B.1.617 .1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
Mas detalles

SARS-CoV-2 RT-PCR Assays
GSD NovaType Select SARS-CoV-2 Assay Family

GSD NovaType Select is a group of RT-PCR assays to discriminate variants of the SARS-CoV-2 virus. The assay family provides the opportunity to assemble a customized RT-PCR assay mutation panel from a basis kit including the enzyme mastermix, and a range of mutation specific sets, including primer, probes and controls. The research use only (RUO) Select assays detect the following mutations: K417N, K417T, L452R, T478K, E484K, P681R and P618H.
Mas detalles

Laboratorio clínico

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

PRUEBA RT-PCR PARA SARS-COV-2
GSD NovaType III SARS-CoV-2

La GSD NovaType III SARS-CoV-2 RT-PCR está desarrollada para la detección rápida de variantes de preocupación del SARS-CoV-2, incluidas B.1.427 / B.1.429 (Epsilon) / B.1.617.2 (Delta), B.1.617 .1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
Mas detalles

SARS-CoV-2 RT-PCR Assays
GSD NovaType Select SARS-CoV-2 Assay Family

GSD NovaType Select is a group of RT-PCR assays to discriminate variants of the SARS-CoV-2 virus. The assay family provides the opportunity to assemble a customized RT-PCR assay mutation panel from a basis kit including the enzyme mastermix, and a range of mutation specific sets, including primer, probes and controls. The research use only (RUO) Select assays detect the following mutations: K417N, K417T, L452R, T478K, E484K, P681R and P618H.
Mas detalles

SARS-CoV-2 IgG ELISA Kit
NovaLisa SARS-CoV-2 IgG

The NovaLisa SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The CE-IVD marked assay demonstrates high sensitivity with antibodies detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group), and a specificity of >98%.
Mas detalles

SARS-CoV-2 Ag Rapid Test (Nasal Swab)
GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab)

The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen. The CE-IVD labeled rapid test detects SARS-CoV-2 antigens in 15 minutes with a diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%.
Mas detalles

SARS-CoV-2 RT-PCR Assay
GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
Mas detalles

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 CROM

The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
Mas detalles

PRUEBA DE ANTICUERPOS CONTRA COVID-19
INgezim COVID 19 DR

El ensayo inmunoabsorbente ligado a enzimas de reconocimiento dual (ELISA), puede detectar semicuantitativamente anticuerpos específicos contra la proteína N del virus SARSCoV-2 en una sola muestra de suero o plasma humano.
Mas detalles

PRUEBA DE SARS-COV-2
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR

La prueba RT-PCR GSD NovaPrime® SARS-CoV-2 (COVID-19) fue diseñada para la determinación cualitativa del ARN genómico del SARS-CoV-2 (síndrome respiratorio agudo severo por el coronavirus 2) extraído de varios tipos de muestras respiratorias humanas.
Mas detalles
Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones